Novel stem cell approach restores motor function in Parkinson’s Disease
20 February 2020 In a remarkable approach to combatting neurodegeneration using stem cells, Florey researchers have achieved preclinical evidence that stem cells grafts can restore motor function in animals with Parkinson’s Disease. Led by Professor Clare Parish, Head…
‘Eureka LIVE’ offers exclusive access to global Medtronic network for local companies: Medtronic seeking partners in innovation
20 February 2020 Note: Due to COVID-19 AusMedTech (and Eureka Live) has been postponed until May 2021. Sydney – 20 February 2020 – Medtronic Australasia is calling for companies across Australia and New Zealand to apply to Eureka…
Immutep Reports Positive TACTI-002 Data
19 February 2020 SYDNEY, AUSTRALIA – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces interim data from its ongoing Phase II TACTI-002 study.…
Test measures immune response to improve ovarian cancer diagnosis
17 February 2020 Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer. Ovarian cancer is one of the most common gynaecologic cancers, with the highest mortality rate. About…
SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide
17 February 2020 Adelaide, South Australia Trajan Nutrition has signed a Memorandum of Understanding with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by…
Erectile Dysfunction a Potential Target for Exopharm’s Exosomes
14 February 2020 An Australian-developed regenerative therapy is exploring the possibility of a treatment for Erectile dysfunction (ED) through stimulating the regenerative and healing capacities of the body. Exopharm Limited (ASX: EX1) has been testing its exosomes –…
The 3-D printed healthcare revolution
12 February 2020 By Michelle Wheeler, freelance science journalist, for Particle Need brain surgery? We’ll get printing now. Imagine you need a complicated and risky operation to insert an implant into your brain. The implant has been custom…
New Australian technology to treat lung disease
12 February 2020 Australian Associated Press Diagnosing lung disease will now be faster and more accurate, thanks to new non-invasive technology developed at Monash University. The technology will enable doctors to check if treatments for respiratory illnesses are…
Patients with challenging cancers to benefit from genomic sequencing
12 February 2020 More than 1000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosis and provide more targeted and effective treatments for cancers of unmet need.…
Work commences on a new global HQ
11 February 2020 World leading biotech company CSL has commenced construction of its global headquarters in Parkville, the nation’s premier biomedical precinct, which will further cement Melbourne’s position as a world class research destination The new purpose-built facility, which…
David McIntyre appointed as non-executive director
12 February 2020 Melbourne, Australia: The Board of Starpharma (ASX: SPL, OTCQX: SPHRY) is pleased to announce the appointment of Mr David McIntyre as an independent non-executive director, effective 1 March 2020. Mr McIntyre has more than 20 years…
Independent Plexaris and Cevaris testing shows positive and unique results
12 February 2020 Melbourne, Australia: BioMAP testing of Exopharm’s exosome platform has validated safety and mechanism of action (MOA) and found that they have different and distinct activities compared to 4,500 other drugs. This confirms this therapeutic approach…
